help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 12, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0737
A more recent version of this article appeared on October 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/10/3691    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Deeb, A
Right arrow Articles by Hughes, I A
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deeb, A
Right arrow Articles by Hughes, I A
Related Collections
Right arrow Male Endocrinology

Submitted on April 3, 2008
Accepted on July 31, 2008

A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions

A Deeb, J Jääskeläinen, M Dattani, H C Whitaker, C Costigan, and I A Hughes*

University Department of Paediatrics, Addenbrooke's Hospital, University of Cambridge, Hills Rd Cambridge CB2 2QQ, UK; Institute of Child Health and Great Ormond Street Hospital, University College London, 30 Guilford Street London WC1N 1EH UK; CRUK Uro-Oncology Group, Department of Oncology, University of Cambridge, MRC/Hutchison Building, Hills Road, Cambridge, CB2 2XZ; Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland

* To whom correspondence should be addressed. E-mail: iah1000{at}cam.ac.uk.

Context: The androgen insensitivity syndrome (AIS) is caused by molecular defects in the androgen receptor (AR). Clinically, the partial form (PAIS) has a variable phenotype. Many mechanisms explain the phenotype in AIS. A crucial step in AR action is the interaction of the N and C termini.

Objective: The role of the hinge region of the AR is not as well understood as other parts of the receptor. We aim to study the role of this region in the N/C termini interaction.

Patient & method: We report a patient with severe undermasculinisation and poor response to exogenous androgens. Androgen binding was performed and the AR gene was sequenced. The mutation was re-created, and transfected in COS-1 cells. Transactivation was studied. N/C termini interaction was studied using a mammalian 2-hybrid assay. Nuclear localisation study was performed.

Results: Androgen binding was normal and a novel mutation (Arg629Trp) in the AR hinge region was identified. Mutant AR transactivation was 40% higher compared to wild-type (WT). A 3-fold increase in transcription occurred when both WT N and C terminal domains were co-transfected; no response occurred when the mutated region of the AR was included (P<0.001). Cells with mutant AR showed a comparable nuclear localization to the WT AR.

Conclusions: A mutation in the hinge region impaired N/C domain interaction in the presence of normal AR binding and nuclear localisation. It resulted in severe undermasculinisation at birth and resistance to androgens. The findings confirm a unique regulatory role for the hinge region in AR function.


Key words: Androgen receptor • hinge region • virilisation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society